Home Usefulness of non-fasting lipid parameters in children
Article
Licensed
Unlicensed Requires Authentication

Usefulness of non-fasting lipid parameters in children

  • Toshihide Kubo EMAIL logo , Kyohei Takahashi , Mahoko Furujo , Yuki Hyodo , Hiroki Tsuchiya , Mariko Hattori , Shoko Fujinaga and Kenji Urayama
Published/Copyright: December 15, 2016

Abstract

Background:

This study assessed whether non-fasting lipid markers could be substituted for fasting markers in screening for dyslipidemia, whether direct measurement of non-fasting low-density lipoprotein cholesterol [LDL-C (D)] could be substituted for the calculation of fasting LDL-C [LDL-C (F)], and the utility of measuring non-high-density lipoprotein cholesterol (non-HDL-C).

Methods:

In 33 children, the lipid profile was measured in the non-fasting and fasting states within 24 h. Correlations were examined between non-fasting LDL-C (D) or non-HDL-C levels and fasting LDL-C (F) levels.

Results:

Non-fasting triglyceride (TG), total cholesterol (TC), HDL-C, LDL-C (D), and non-HDL-C levels were all significantly higher than the fasting levels, but the mean difference was within 10% (except for TG). Non-fasting LDL-C (D) and non-HDL-C levels were strongly correlated with the fasting LDL-C (F) levels.

Conclusions:

In conclusion, except for TG, non-fasting lipid parameters are useful when screening children for dyslipidemia. Direct measurement of non-fasting LDL-C and calculation of non-fasting non-HDL-C could replace the calculation of fasting LDL-C because of convenience.


Corresponding author: Toshihide Kubo, MD, PhD, Department of Pediatrics, National Hospital Organization, Okayama Medical Center, 1711-1 Tamasu, Kita-ku, Okayama 701-1192, Japan, Phone: +81-86-294-9911, Fax: +81-86-294-9255

  1. Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission. Kubo T designed this study; Takahashi K analyzed the data; the other authors acquired the data. Kubo T drafted the manuscript, and the other authors revised it.

  2. Research funding: This research was supported by the National Hospital Organization, Okayama Medical Center.

  3. Employment or leadership: None declared.

  4. Honorarium: None declared.

  5. Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.

References

1. Daniels SR, Greer FR; American Academy of Pediatrics, Committee on Nutrition. Lipid screening and cardiovascular health in childhood. Pediatrics 2008;122:198–208.10.1542/peds.2008-1349Search in Google Scholar PubMed

2. Committee on Practice and Ambulatory Medicine and Bright Futures Periodicity Schedule Workgroup. 2016 Recommendations for preventive pediatric health care. Pediatrics 2016;137:25–27.Search in Google Scholar

3. Chung JY, Kang HT, Shin YH, Lee HR, Park BJ, et al. Prevalence of metabolic syndrome in children and adolescents-the percent trends in South Korea. J Pediatr Endocr Met 2013;26:105–10.Search in Google Scholar

4. Li P, Jiang R, Li L, Liu C, Yang F, et al. Prevalence and risk factors of metabolic syndrome in school adolescents of northeast China. J Pediatr Endocr Met 2014;27:525–32.10.1515/jpem-2013-0336Search in Google Scholar PubMed

5. Friedewald WT, Levy RI, Fredrickson S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499–502.10.1093/clinchem/18.6.499Search in Google Scholar

6. Sidhu D, Naugler C. Fasting time and lipid levels in a community-based population. Arch Intern Med 2012;172:1707–10.10.1001/archinternmed.2012.3708Search in Google Scholar PubMed

7. Steiner MJ, Skinner AC, Perrin EM. Fasting might not be necessary before lipid screening: a nationally representative cross-sectional study. Pediatrics 2011;128:463–70.10.1542/peds.2011-0844Search in Google Scholar PubMed PubMed Central

8. Langsted A, Freiberg JJ, Nordestgaard BG. Fasting and nonfasting lipid levels: influence of normal food intake on lipids, lipoproteins, apolipoproteins, and cardiovascular risk prediction. Circulation 2008;118:2047–56.10.1161/CIRCULATIONAHA.108.804146Search in Google Scholar PubMed

9. Naugler C, Sidhu D. Break the fast?: update on patient preparation for cholesterol testing. Can Fam Physician 2014;60:895–7.Search in Google Scholar

10. Mora S, Rifai N, Buring JE, Ridker PM. Fasting compared with nonfasting lipids and apolipoproteins for predicting incident cardiovascular events. Circulation 2008;118:993–1001.10.1161/CIRCULATIONAHA.108.777334Search in Google Scholar PubMed PubMed Central

11. Mora S, Rifai N, Buring JE, Ridker PM. Comparison of LDL cholesterol concentrations by Friedewald calculation and direct measurement in relation to cardiovascular events in 27,331 women. Clin Chem 2009;55:888–94.10.1373/clinchem.2008.117929Search in Google Scholar PubMed PubMed Central

12. Ferranti S, Shapiro D, Markowitz R, Neufeld E, Rifai N, et al. Nonfasting low-density lipoprotein testing: utility for cholesterol screening in pediatric primary care. Clin Pediatr (Phila) 2007;46:441–5.10.1177/0009922806297752Search in Google Scholar PubMed

13. Anderson TJ, Gregoire J, Hegele RA, Couture P, Mancini GB, et al. 2012 Update of the Canadian Cardiovascular Society Guidelines for the diagnosis and treatment of dyslipidemia for the prevention of cardiovascular disease in the adult. Can J Cardiol 2013;29:151–67.10.1016/j.cjca.2012.11.032Search in Google Scholar PubMed

14. Frontini MG, Srinivasan SR, Xu J, Tang R, Bond M, et al. Usefulness of childhood non-high density lipoprotein cholesterol levels versus other lipoprotein measures in predicting adult subclinical atherosclerosis; the Bogalusa Heart Study. Pediatrics 2008;121:924–9.10.1542/peds.2007-1472Search in Google Scholar

15. Bamba V. Update on screening, etiology, and treatment of dyslipidemia in children. J Clin Endocrinol Metab 2014;99: 3093–102.10.1210/jc.2013-3860Search in Google Scholar

16. Asayama K, Ozeki T, Sugihara S, Ito K, Okada T, et al. Criteria for medical intervention in obese children: a new definition of ‘obesity disease’ in Japanese children. Pediatric Int 2003;45:642–6.10.1046/j.1442-200X.2003.01795.xSearch in Google Scholar

17. Okada T, Murata M, Yamaguchi K, Harada K. New criteria of normal serum lipid levels in Japanese children: the nationwide study. Pediatric Int 2002;44:596–601.10.1046/j.1442-200X.2002.01634.xSearch in Google Scholar

18. Abe y, Okada T, Sugiura R, Yamauchi K, Murata M. Reference ranges for the non-high-density lipoprotein cholesterol levels in Japanese children and adolescents. J Atheroscler Thromb 2015;22:669–75.10.5551/jat.28100Search in Google Scholar

19. Newman WP III, Freedman DS, Vores AW, Gard PD, Srinivasan SR, et al. Relation of serum lipoprotein levels and systolic blood pressure to early atherosclerosis. The Bogalusa Heart Study. N Engl J Med 1986;314:138–44.10.1056/NEJM198601163140302Search in Google Scholar

20. Srinivasan SR, Berenson GS. Childhood lipoprotein profiles and implications for adult coronary artery disease: the Bogalusa Heart Study. Am J Med Sci 1995;310(Suppl 1):S62–7.10.1097/00000441-199512000-00011Search in Google Scholar

21. Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III): final report. Circulation 2002;106:3143–421.10.1161/circ.106.25.3143Search in Google Scholar

22. De Backer G, Ambrosioni E, Borch-Johnsen K, Brotons C, Cifkova R, et al. European guidelines on cardiovascular disease prevention in clinical practice: third Joint Task Force of European and other Societies on Cardiovascular Disease Prevention in Clinical Practice. Eur Heart J 2003;24:1601–10.10.1016/S0195-668X(03)00347-6Search in Google Scholar

23. Schaefer EJ, Audelin MC, McNamara JR, Shah PK, Tayler T, et al. Comparison of fasting and postprandial plasma lipoproteins in subjects with and without coronary heart disease. Am J Cardiol 2001;88:1129–33.10.1016/S0002-9149(01)02047-1Search in Google Scholar

24. Nordestgaard BG, Benn M, Schnohr P, Tybjaerg-Hansen A. Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women. J Am Med Assoc 2007;298:299–308.10.1001/jama.298.3.299Search in Google Scholar PubMed

25. Pischon T, Girman CJ, Sacks FM, Rifani N, Stampfer MJ, et al. Non-high density lipoprotein cholesterol apolipoprotein B in the prediction of coronary heart disease in men. Circulation 2005;112:3375–83.10.1161/CIRCULATIONAHA.104.532499Search in Google Scholar PubMed

Received: 2016-7-7
Accepted: 2016-11-3
Published Online: 2016-12-15
Published in Print: 2017-1-1

©2017 Walter de Gruyter GmbH, Berlin/Boston

Articles in the same Issue

  1. Frontmatter
  2. Editorial
  3. Disorders of sex development
  4. Original Articles
  5. Fertility and sexual function: a gap in training in pediatric endocrinology
  6. Disorders of sex development in children in KwaZulu-Natal Durban South Africa: 20-year experience in a tertiary centre
  7. Novel mutations of the SRD5A2 and AR genes in Thai patients with 46, XY disorders of sex development
  8. Sensitivity and specificity of different methods for cystic fibrosis-related diabetes screening: is the oral glucose tolerance test still the standard?
  9. Anti-hyperglycemic activity of Aegle marmelos (L.) corr. is partly mediated by increased insulin secretion, α-amylase inhibition, and retardation of glucose absorption
  10. Risk factors that affect metabolic health status in obese children
  11. Nocturnal levels of chemerin and progranulin in adolescents: influence of sex, body mass index, glucose metabolism and sleep
  12. Elevated endogenous secretory receptor for advanced glycation end products (esRAGE) levels are associated with circulating soluble RAGE levels in diabetic children
  13. Food exchange estimation by children with type 1 diabetes at summer camp
  14. Usefulness of non-fasting lipid parameters in children
  15. Monitoring steroid replacement therapy in children with congenital adrenal hyperplasia
  16. Clinical and molecular characterization of Beckwith-Wiedemann syndrome in a Chinese population
  17. An analysis of the sequence of the BAD gene among patients with maturity-onset diabetes of the young (MODY)
  18. Case Reports
  19. Hypogonadotropic hypogonadism in a female patient with congenital arhinia
  20. Transdermal testosterone gel for induction and continuation of puberty in adolescent boys with hepatic dysfunction
  21. Long-term response to growth hormone therapy in a patient with short stature caused by a novel heterozygous mutation in NPR2
  22. Three cases of Japanese acromicric/geleophysic dysplasia with FBN1 mutations: a comparison of clinical and radiological features
Downloaded on 8.11.2025 from https://www.degruyterbrill.com/document/doi/10.1515/jpem-2016-0271/html
Scroll to top button